Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Sell
45
PWOD Quote, Financials, Valuation and Earnings
Last price:
$30.67
Seasonality move
:
-3.73%
Day range:
$30.47 - $32.00
52-week range:
$17.01 - $34.56
Dividend yield:
4.19%
P/E ratio:
11.57x
P/S ratio:
3.43x
P/B ratio:
1.13x
Volume:
33.2K
Avg. volume:
24.4K
1-year change:
29.79%
Market cap:
$230.7M
Revenue:
$63.3M
EPS (TTM):
$2.64
Analysts' Opinion
-
Consensus RatingPenns Woods Bancorp has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Penns Woods Bancorp has an estimated downside of -- from its current price of $30.54.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $30.54.
Fair Value
-
According to the consensus of 0 analysts, Penns Woods Bancorp has -- downside to fair value with a price target of -- per share.
PWOD vs. S&P 500
-
Over the past 5 trading days, Penns Woods Bancorp has underperformed the S&P 500 by -11.21% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Penns Woods Bancorp does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Penns Woods Bancorp has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Penns Woods Bancorp reported revenues of $17.5M.
Earnings Growth
-
Penns Woods Bancorp has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Penns Woods Bancorp reported earnings per share of $0.64.
Enterprise value:
249.4M
EV / Invested capital:
0.54x
Price / LTM sales:
3.43x
EV / EBIT:
3.37x
EV / Revenue:
3.76x
PEG ratio (5yr expected):
0.55x
EV / Free cash flow:
21.67x
Price / Operating cash flow:
19.80x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.88%
Net Income Margin (TTM):
29.45%
Return On Equity:
10.18%
Return On Invested Capital:
4.01%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $65M | $64.8M | $66.4M | $15.2M | $17.5M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $2.52 | $2.18 | $2.64 | $0.31 | $0.64 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $384.5M | $456.9M | $233.7M | $230.8M | $248.6M | |
| Total Assets | $1.8B | $1.9B | $1.9B | $2.2B | $2.3B | |
| Current Liabilities | $16.5M | $10.2M | $31.3M | $196.5M | $83.8M | |
| Total Liabilities | $1.7B | $1.7B | $1.7B | $2B | $2.1B | |
| Total Equity | $162.4M | $168.5M | $164.5M | $174.5M | $203.7M | |
| Total Debt | $148M | $118M | $95M | $240M | $255.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $24.2M | $19.5M | $12.9M | -$808K | -$1.6M | |
| Cash From Investing | -$255.3M | -$267.5M | -$61.2M | -$49.1M | -$11.2M | |
| Cash From Financing | -$13.6M | $246.8M | $52.4M | $40.6M | $17.4M | |
| Free Cash Flow | $23.7M | $18.9M | $11.5M | -$870K | -$1.8M | |
PWOD
Sector
Market Cap
$230.7M
$694.9M
Price % of 52-Week High
88.37%
87.97%
Dividend Yield
4.19%
2.23%
Shareholder Yield
-0.69%
3.88%
1-Year Price Total Return
29.79%
8.55%
Beta (5-Year)
0.482
0.737
Dividend yield:
4.19%
Annualized payout:
$1.28
Payout ratio:
49.16%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$32.01
200-day SMA
Buy
Level
$22.89
Bollinger Bands (100)
Buy
Level
21.96 - 30.12
Chaikin Money Flow
Sell
Level
-599.7K
20-day SMA
Sell
Level
$32.50
Relative Strength Index (RSI14)
Sell
Level
45.12
ADX Line
Buy
Level
13.39
Williams %R
Buy
Level
-91.7808
50-day SMA
Buy
Level
$29.40
MACD (12, 26)
Buy
Level
0.47
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Sell
Level
-766.2K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2813)
Sell
CA Score
(Annual)
Level (-2.2354)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (2.8172)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.
Stock Forecast FAQ
In the current month, PWOD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PWOD average analyst price target in the past 3 months is --.
-
Where Will Penns Woods Bancorp Stock Be In 1 Year?
According to analysts, the consensus estimate is that Penns Woods Bancorp share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Penns Woods Bancorp?
Analysts are divided on their view about Penns Woods Bancorp share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Penns Woods Bancorp is a Sell and believe this share price will rise from its current level to --.
-
What Is Penns Woods Bancorp's Price Target?
The price target for Penns Woods Bancorp over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PWOD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Penns Woods Bancorp is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PWOD?
You can purchase shares of Penns Woods Bancorp via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Penns Woods Bancorp shares.
-
What Is The Penns Woods Bancorp Share Price Today?
Penns Woods Bancorp was last trading at $30.67 per share. This represents the most recent stock quote for Penns Woods Bancorp. Yesterday, Penns Woods Bancorp closed at $30.54 per share.
-
How To Buy Penns Woods Bancorp Stock Online?
In order to purchase Penns Woods Bancorp stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is down 8.7% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is up 9.77% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is up 7.96% over the past day.
